Sai Life Sciences Board Meeting on Nov 5 to Approve Q2 FY27 Results

Sai Life Sciences Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item for this meeting is the consideration and approval of the company's standalone and consolidated unaudited financial results for the second quarter and half-year period ending September 30, 2026. Additionally, other corporate matters will be discussed. The trading window for designated persons and their relatives, which opened on October 1, 2026, will remain closed until 48 hours after the announcement of these financial results, extending up to November 7, 2026.